Profile data is unavailable for this security.
About the company
Beijing Kawin Technology Share-Holding Co Ltd is a China-based company principally engaged in the production and sales of therapeutic drugs in the viral disease field, and the research and development of innovative drugs. The Company's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The Company mainly distributes its products within domestic market.
- Revenue in CNY (TTM)1.42bn
- Net income in CNY134.34m
- Incorporated2008
- Employees584.00
- LocationBeijing Kawin Technology Share-Holding Co LtdNo. 6 Rongjing East Street, EconomicTechnological Development ZoneBEIJING 100176ChinaCHN
- Phone+86 1 087120888
- Fax+86 1 067872896
- Websitehttps://www.kawin.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qingdao Vland Biotech INC | 1.26bn | 66.23m | 3.52bn | 1.57k | 52.84 | 2.04 | -- | 2.78 | 0.2631 | 0.2631 | 5.02 | 6.83 | 0.425 | 3.78 | 3.76 | 805,143.80 | 3.25 | 5.78 | 5.09 | 7.89 | 44.98 | 46.13 | 7.65 | 10.34 | 0.9248 | 11.63 | 0.2904 | 33.59 | 3.07 | 8.05 | 15.56 | -0.6507 | 24.68 | -6.89 |
| Hinova Pharmaceuticals Inc | 109.74k | -210.18m | 3.59bn | 179.00 | -- | 2.92 | -- | 32,725.49 | -2.12 | -2.12 | 0.0011 | 12.44 | 0.00007 | 7.12 | 0.0805 | 613.07 | -14.10 | -31.86 | -15.71 | -37.18 | -450.31 | -- | -191,529.30 | -25,578.24 | 6.38 | -- | 0.0457 | -- | -100.00 | -- | 2.44 | -- | 124.37 | -- |
| Bide Pharmatech Co Ltd | 1.10bn | 80.03m | 4.20bn | 846.00 | 51.49 | 2.10 | -- | 3.83 | 0.8983 | 0.8983 | 12.25 | 21.98 | 0.4608 | 0.9359 | 4.51 | 1,298,144.00 | 3.34 | -- | 3.82 | -- | 40.11 | -- | 7.25 | -- | 4.59 | -- | 0.0492 | -- | 30.94 | -- | -24.94 | -- | -- | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 497.71m | 103.71m | 4.36bn | 566.00 | 35.39 | 4.19 | -- | 8.76 | 0.4439 | 0.4439 | 1.98 | 3.75 | 0.3103 | 0.3818 | 9.08 | 879,345.60 | 7.20 | 8.83 | 8.22 | 9.61 | 61.57 | 61.49 | 23.21 | 26.85 | 3.10 | 113.47 | 0.2781 | 45.71 | 6.55 | 19.36 | -7.48 | 9.95 | 31.41 | -- |
| Jiangsu Yahong Meditech Co Ltd | 149.71m | -403.23m | 4.41bn | 394.00 | -- | 2.12 | -- | 29.47 | -0.7074 | -0.7074 | 0.2627 | 3.65 | 0.0598 | 16.64 | 6.92 | 379,971.80 | -16.14 | -15.80 | -17.15 | -16.48 | 78.63 | 55.32 | -269.87 | -9,445.91 | 8.97 | -- | 0.0599 | -- | 52,594.79 | -- | -62.42 | -- | 64.28 | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.42bn | 134.34m | 4.61bn | 584.00 | 33.01 | 2.48 | -- | 3.25 | 0.8175 | 0.8175 | 8.53 | 10.87 | 0.5736 | 1.80 | 3.27 | 2,431,971.00 | 6.49 | 5.31 | 8.52 | 6.76 | 81.80 | 86.02 | 11.31 | 8.10 | 2.91 | -- | 0.141 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.16bn | 221.37m | 4.79bn | 1.39k | 21.62 | 4.23 | -- | 4.14 | 1.98 | 1.98 | 10.33 | 10.10 | 0.6079 | 35.95 | 1.77 | 844,377.10 | 11.25 | 12.99 | 18.76 | 21.70 | 53.30 | 53.93 | 18.50 | 21.34 | 1.86 | 29.92 | 0.3068 | 10.74 | 37.76 | 47.22 | 18.08 | 54.90 | 34.77 | -- |
| HitGen Inc | 423.87m | 52.55m | 5.08bn | 452.00 | 96.47 | 3.69 | -- | 11.99 | 0.1314 | 0.1314 | 1.06 | 3.44 | 0.248 | 7.10 | 4.55 | 937,755.30 | 2.99 | 4.63 | 3.16 | 5.10 | 51.23 | 58.89 | 12.05 | 20.66 | 16.15 | 38.23 | 0.1391 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
| Shanghai Medicilon Inc | 984.17m | -276.79m | 5.11bn | 2.42k | -- | 2.17 | -- | 5.19 | -2.01 | -2.01 | 7.23 | 17.46 | 0.3029 | 6.90 | 1.27 | 378,525.60 | -8.52 | 9.34 | -10.66 | 11.73 | 0.6443 | 36.71 | -28.12 | 14.93 | 2.64 | -- | 0.1147 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
| GemPharmatech Co Ltd | 677.34m | 139.41m | 5.63bn | 1.51k | 40.00 | 2.64 | -- | 8.30 | 0.343 | 0.343 | 1.65 | 5.20 | 0.2703 | 4.54 | 2.06 | 449,761.40 | 5.56 | 9.45 | 6.39 | 11.13 | 63.04 | 70.21 | 20.58 | 28.16 | 4.74 | -- | 0.0509 | 14.68 | 20.45 | 63.48 | -3.48 | -- | 141.38 | -- |
| InventisBio Co Ltd | 77.51m | -348.02m | 6.17bn | 221.00 | -- | 3.56 | -- | 79.61 | -0.6064 | -0.6064 | 0.1346 | 3.01 | 0.0383 | -- | 0.5855 | 350,739.20 | -17.19 | -- | -18.36 | -- | 90.80 | -- | -448.98 | -- | -- | -- | 0.0138 | -- | -- | -- | 41.26 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Beijing Kawin Technology Share-Holding Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
28.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Sep 2024 | 14.67m | 12.89% |
| Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2024 | 5.23m | 4.60% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2024 | 2.25m | 1.97% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2024 | 2.18m | 1.92% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 1.99m | 1.75% |
| HSBC Jintrust Fund Management Co. Ltd.as of 30 Jun 2024 | 1.52m | 1.34% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2024 | 1.41m | 1.24% |
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2024 | 1.07m | 0.94% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 965.17k | 0.85% |
| Golden Eagle Asset Management Co., Ltd.as of 30 Jun 2024 | 899.90k | 0.79% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
